BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.

Company Data

Name BLACKROCK HEALTH SCIENCES TRUST II OF BENEFICIAL INTEREST

Company BlackRock Health Sciences Trust II

Symbol BMEZ

Website https://www.blackrock.com

Primary Exchange

NYSE

ISIN US09260E1055

Asset Class Share

Sector Financial Services

Industry Asset Management

CEO Xiang Liu

Market Capitalization 1 Mrd.

Country United States of America

Currency USD

Employees -

Address 55 East 52nd Street, 10055 New York City

IPO Date 2020-01-29

Dividends from 'BLACKROCK HEALTH SCIENCES TRUST II OF BENEFICIAL INTEREST'

Ex-Date	Dividend per Share
15.09.2025	0,16 USD
15.08.2025	0,16 USD
15.07.2025	0,17 USD
13.06.2025	0,17 USD
15.05.2025	0,17 USD
15.04.2025	0,17 USD
14.03.2025	0,18 USD
14.02.2025	0,18 USD
15.01.2025	0,18 USD
16.12.2024	0,18 USD

Ticker Symbols

Name	Symbol
Frankfurt	0PR.F
NYSE	BMEZ

More Shares

Investors who hold BLACKROCK HEALTH SCIENCES TRUST II OF BENEFICIAL INTEREST also have the following shares in their portfolio:

ANHEU.-BUSCH 20/40 MTN Bond

LBBW NK-STUFENZINS 17/22 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog